Intercept Pharmaceuticals Competitors and Similar CompaniesClear all
Intercept Pharmaceuticals's competitors and similar companies include Ipsen.
 Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. | ||
Founding Date | Founding Date 2002 | Founding Date 1929 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees 58321% increase | Employees 5,358 |
Valuation ($) | Valuation ($) 794.7 m | Valuation ($) 10.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) €3.7b (FY, 2025) |
Cost of goods | Cost of goods $984k (FY, 2022) | Cost of goods €659.1m (FY, 2025) |
Gross profit | Gross profit $284.7m (FY, 2022) | Gross profit €3.3b (FY, 2025) |
Net income | Net income $221.8m (FY, 2022) | Net income €445.1m (FY, 2025) |
For sources of this data, please see the company profile